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Abstract
Purpose: Randomized controlled trials (RCTs) allow reliable causal inferences to be drawn 
regarding the effectiveness of specific interventions. However, they are expensive to carry out, and 
not all exposure-outcome relationships can be tested in an RCT framework: for example, it would 
be unethical to deliberately expose participants to a putative risk factor, or the time-scale involved 
may be prohibitive. Mendelian randomization (MR) has been proposed as an alternative approach 
for drawing causal inferences, with the major advantage that the method can often be applied to 
existing, cross-sectional study datasets. Therefore, results from an MR study can be obtained much 
more quickly and cheaply than through an RCT. 
Recent findings: The validity of causal inferences from an MR study are dependent on two key 
assumptions, neither of which can be tested fully. Nevertheless, several approaches have been 
proposed in the last three years that either highlight questionable results, or provide valid causal 
inference if the necessary assumptions are met only in part. Compared to certain other areas of 
clinical practice, the ophthalmic research community has been slow to adopt MR.
Summary: An MR study cannot match an RCT in its strength of evidence for a claim of causality. 
However, MR still has much to offer. In some circumstances, an MR study can provide causal insight 
into research questions that cannot be addressed by an RCT, while more generally, an MR study can 
be used to evaluate the supporting evidence before deciding to embark on a lengthy and costly RCT. 
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INTRODUCTION
Terminology
The glossary section explains the meaning of technical terms frequently encountered in the 
Mendelian randomization literature, including in this review: assortative mating; collider bias; 
directional pleiotropy; funnel plot; genetic variant; genome-wide association study (GWAS); 
horizontal and vertical pleiotropy; instrument strength independent of direct effect (InSIDE) 
assumption; instrumental variable; weak instrument bias.
What is Mendelian Randomization?
Mendelian randomization (MR) is an epidemiology research method designed to estimate the 
causal effect of exposure to a putative risk factor on an outcome.1,2 An example would be a study 
designed to test whether, and to what degree, additional dietary intake of carotenoids reduces the 
risk of age-related macular degeneration (AMD). In this example, the exposure of interest is 
‘additional dietary intake of carotenoids’ and the outcome of interest is AMD. In contrast to a 
randomized controlled trial (RCT), which is generally regarded as the gold-standard research 
method for drawing causal inferences in epidemiology, MR can be applied to cross-sectional data 
obtained from observational studies.3 Thus, whereas addressing a research question by running an 
RCT requires a considerable investment in time and resources, running an MR study potentially 
offers a fast and cost-efficient alternative approach that can utilize existing, large-scale cross-
sectional datasets.
Standard cross-sectional analyses of observational data have a poor track record of successfully 
identifying modifiable risk factors,1 as exemplified by the caveat, ‘association does not imply 
causation’. A key limitation of standard cross-sectional methods is bias from confounders (a 
confounder is defined as a variable with causal effects on both the exposure and the outcome). In 
the carotenoids-AMD example, the list of potential confounders would include factors such as 
socioeconomic position, level of education, and ethnicity. For instance, wealthier, health-conscious 
individuals might choose to eat a diet rich in carotenoids while also engaging in other behaviours 
that reduced their risk of AMD independently of dietary carotenoid intake.4 In this scenario, an 
association between (reduced) carotenoid intake and AMD could arise in the absence of a causal 
relationship. Standard cross-sectional analyses are also susceptible to ‘reverse causation’, the 
situation in which an outcome has a causal influence on the exposure of interest. For example, 
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reverse causation could result in a non-causal association between AMD and dietary carotenoid 
intake if patients diagnosed with AMD were recommended by their eye-care provider to eat a diet 
rich in carotenoids.4 MR is free from bias due to reverse causation, and – as discussed below – is 
generally less prone to bias from confounders such as socioeconomic position than standard 
observational analyses. 
MR is an example of an ‘instrumental variable’ analysis method.5,6 An instrumental variable, also 
known as an ‘instrument’, is a variable that meets the following 3 criteria: (1) it is robustly 
associated with the exposure of interest, (2) it is not associated with confounders of the exposure-
outcome relationship, and (3) it is not associated with the outcome except via the exposure. These 
criteria are most readily understood with reference to a pathway diagram, such as Figure 1, which 
illustrates causal relationships between variables using arrows (where A  B is interpreted as, 
‘Variable A is a cause of variable B’). To be a valid instrumental variable, coefficient 1 must be non-
zero (criterion #1), coefficient 5 must be zero (criterion #2), and coefficient 6 must be zero 
(criterion #3). 
Instrumental variables enable the causal effects of an exposure to be assessed by supplying a 
‘causal handle’ for the exposure of interest that is unrelated to, i.e. statistically independent of, the 
confounders.7,8 The effects on the outcome resulting from a change in the level of the exposure 
variable can therefore be assessed free from the influence of the confounders, and free from the 
effects of reverse causation. In MR, the instrumental variable is a genetic variant associated with the 
exposure variable, or a collection of such genetic variants. This concept of using genetic variants to 
obtain evidence for a causal effect free from reverse causation and confounder bias is generally 
attributed to Katan9 (although the necessary data were not available for Katan to test the specific 
hypothesis he had in mind: that the link between low serum cholesterol and the risk of cancer was 
non-causal). The term ‘Mendelian randomization’ was first used10 by Gray and Wheatley in 1991 
when describing the advantages of MR over an RCT study design to assess the efficacy of allogenic 
bone marrow transplantation vs. ‘conventional’ therapy. They advocated, and carried out a pilot 
study, comparing outcomes in children with leukaemia whose sibling were vs. were not compatible 
(genetically matched) for a bone marrow transplant. 
Assumptions inherent to Mendelian Randomization
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In order for a genetic variant to be a valid instrumental variable, it must meet all 3 of the criteria 
listed above. It is straightforward to choose a genetic variant that meets criterion #1 (i.e. that the 
genetic variant is robustly associated with the exposure) and to test that this assumption is met. 
Typically, genetic variants identified in a genome-wide association study (GWAS) for the exposure 
trait that exceed the genome-wide statistical significance threshold (typically P < 5 x 10-8) are 
chosen for use in MR analyses. Their validity can be confirmed by testing for an association with the 
exposure in an independent dataset (but see the discussion of ‘weak instruments’ in the ‘Few vs. 
many genetic variants’ section). By contrast, it is not possible to test fully that criteria #2 and #3 are 
met. Lack of an association between the genetic variant and known confounders can be confirmed, 
but clearly not all confounders will be known or measurable for many exposure-outcome 
relationships of interest. Genetic variants with pleiotropic effects (defined as effects on more than 
one trait) are therefore potentially problematic, since this could mean the variant is not a valid 
instrumental variable.
Of the various ways of classifying pleiotropy, two are central to the validity of the MR assumptions: 
horizontal pleiotropy and vertical pleiotropy. A genetic variant that exhibits vertical pleiotropy has 
a causal relationship with the exposure via a path that is indirect, i.e. a relationship with the 
exposure variable that is mediated by one or more intermediate trait(s). This genetic variant does 
satisfy the 3 instrumental variable criteria and therefore can be used to draw valid causal 
inferences in an MR analysis. In contrast, a genetic variant displaying horizontal pleiotropy exerts 
effects on the outcome via two or more causal pathways: a pathway via the exposure of interest and 
at least one pathway acting via another route. Such a variant does not satisfy instrumental variable 
criterion #3, and therefore would not be valid for use in an MR study.
While much attention has been focused on the issue of pleiotropy in MR studies, the potential for 
‘collider bias’ has rarely been raised11 (a collider is defined as a variable influenced independently 
by two or more other variables; collider bias is defined as bias in an exposure-outcome relationship 
induced by ‘conditioning on’, or stratifying the sample by, a collider12). Commonly encountered 
reasons for collider bias to occur are selection bias12 and survivor bias.13 Regarding the AMD 
example discussed above, health-conscious individuals may choose to participate in a research 
study more often than less health-conscious individuals. Likewise, participants with AMD might 
choose to participate more often than those not affected by AMD. In this scenario, in which both 
being health-conscious and having AMD are associated with participation, participation is a 
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collider: therefore, genetic variants associated with being health conscious could produce a biased 
causal effect estimate in an MR study investigating if a healthy lifestyle influences the risk of AMD. 
Similarly, the fact that health-conscious individuals will on average live longer than less health-
conscious individuals – and will therefore be more likely to suffer AMD during their lifetime – could 
also potentially introduce bias (for example, if a genetic variant used as an instrumental variable in 
MR was associated with AMD via an effect on mortality).13
Relationship between Mendelian Randomization and Randomized Controlled Trials
In an RCT, random assignment to the intervention or control group has the dual role of modifying 
the level of the exposure in the intervention group whilst ensuring that levels of confounder 
variables are balanced between the 2 groups (panel A of Figure 2). The random assortment of 
alleles during meiosis (Mendel’s second law), which holds true for the vast majority of genetic loci, 
provides an analogy between an RCT and MR.14,15 In an MR analysis, the assumption is made that 
the assortment of alleles is independent of levels of the confounder variables, i.e. that assortment is 
indeed random (panel B of Figure 2). This assumption seems highly plausible; for instance, 
socioeconomic position would be very unlikely to sway the inheritance of one allele over another. 
An important exception to this rule is ethnicity: allele frequencies vary widely between populations 
of differing ancestry or demographic history, therefore alleles associated with an exposure may also 
be associated with levels of confounder variables – a phenomenon termed ‘population 
stratification’. As an example, individuals from one ethnic group may choose to eat a vegetarian diet 
that is not only rich in carotenoids but also in a number of other dietary components that may 
influence the risk of AMD. For this reason, it is essential for MR studies to account for ethnic 
background in their design. Typically this is done by restricting the analysis to individuals of a 
single, homogenous, genetically-inferred ancestry group. The results of an MR study will only be 
relevant to the chosen study population, and hence may not necessarily be applicable more widely. 
Another potential exception to the random inheritance of specific alleles is assortative mating.16 For 
example, if (i) taller individuals tend to choose each other as spouses (single trait assortative 
mating) and height, education and refractive error have genetic determinants in common, or (ii) 
myopic individuals are more likely to choose better educated spouses (so-called cross-trait 
assortative mating), then a Mendelian randomization analysis testing for a causal effect of 
education on myopia could produce biased results. 
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There are other important differences between MR and an RCT. The alleles used as instrumental 
variables in MR usually produce very small changes in the level of the exposure variable, whereas in 
RCTs the intervention typically has a much larger effect. In order to gauge whether MR results 
would be clinically meaningful, the results are generally assumed to scale linearly. For example, if a 
genetic variant imparts a change in exposure level of x and this is associated with a change of y in 
the outcome, then it is assumed that a change in exposure of 100  x will cause a change in the 
outcome of 100  y. Another fundamental difference between RCTs and MR is that in an RCT, the 
intervention is introduced at a specific point during the lifecourse, while in MR the change in 
exposure imparted via inheritance will have been present from conception. For this reason it can be 
argued that an MR study can never provide proof that an intervention will succeed in the clinical 
environment, even if all MR assumptions are fully met.14,15,17 Thus, it has been suggested that MR 
studies are well-suited as rapid, inexpensive preliminary tests of novel interventions that can be 
used to prioritize investment in RCTs.
FUNDAMENTAL METHODOLOGICAL CONSIDERATIONS
Few vs. many genetic variants
MR studies can be performed with just a single genetic variant, with multiple variants, or with a 
‘genetic risk score’ (also known as an ‘allele score’) calculated by summing the effects of multiple 
variants. In early MR investigations, the genetic variants chosen as instrumental variables were 
typically few in number and had known functional relevance to the exposure of interest. For 
example, to examine the relationship between serum complement factor-H (CFH) levels and AMD, 
Sharma et al.18 tested a single genetic variant (rs1061170) within the CFH gene coding region, 
which they suspected to lower serum CFH levels. The rs1061170 variant’s alleles, T and C, code for 
a tyrosine or histidine (amino acid symbol Y and H), respectively, at amino acid 402 of the CFH 
protein; hence, termed the Y402H polymorphism. Sharma et al.’s MR analysis was carried out under 
the assumption that the C allele reduced serum CFH levels,18 however other work suggests this not 
to be the case.19,20 By contrast, Cuellar-Partida et al.21 created a genetic risk score by combining 
17,749 genetic variants associated with educational attainment in order to study the causal impact 
of education on myopia. 
It is rarely possible to find more than a handful of genetic variants associated with an exposure 
whose mechanisms of action have been established. Therefore, a disadvantage of using multiple 
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genetic variants for an MR analysis (whether combined into a genetic risk score or not) is that the 
molecular/physiological pathway between the variant and the exposure is typically unknown. This 
risks at least some of the variants having a horizontally pleiotropic relationship with the outcome 
and thus biasing the MR causal effect estimate. Balancing this risk is the potentially greater 
precision that can be obtained from using multiple variants (so long as each variant is robustly 
associated with the exposure; otherwise weak instrument bias may actually worsen precision). 
Moreover, using multiple variants provides an opportunity to test for pleiotropic effects (see the 
‘Sensitivity Analyses and New Directions’ section). Hence, there has been a tendency for recent MR 
studies to use tens or hundreds of variants.
Combining genetic variants into a genetic risk score22 protects against ‘weak instrument bias’. The 
latter phenomenon occurs when an MR analysis has insufficient statistical power, i.e. the genetic 
effect of the instrument variable is too small, given the sample size of the study, to adequately gauge 
the true causal effect. Crucially, rather than biasing the causal effect estimate towards zero, weak 
instrument bias in the ‘1-sample’ setting (see the ‘One-sample vs. two-sample Mendelian 
Randomization’ section) biases the causal effect estimate towards that estimated in a standard 
cross-section analysis. In this situation, an MR result may be given undeserved credence when in 
reality it is no better than that obtained from a standard, ordinary least squares analysis. The 
disadvantage of combining genetic variants into a genetic risk score is that they can no longer be 
used to test for pleiotropy (see the ‘Sensitivity Analyses and New Directions’ section). Also, in order 
to combine information into a genetic risk score the researcher must have access to ‘individual 
level’ genetic data (the genotypes of each participant in the sample). Frequently, only ‘summary 
level’ data are available for reasons of privacy, which thus rules out the option of conducting a 
genetic risk score MR analysis. If individual level data are available, there is nothing to stop the 
investigator performing a genetic risk score MR analysis followed by a multiple variant MR 
sensitivity analysis.
One-sample vs. two-sample Mendelian Randomization
In 1-sample MR, the association of the genetic variants with both the exposure and the outcome is 
estimated in a single sample of participants. In a 2-sample MR, the degree of association with the 
exposure and with the outcome are estimated in different samples.23 As mentioned above, a key 
advantage of the 2-sample MR study design is protection against ‘weak instrument bias’, since in 
the 2-sample setting lack of statistical power will bias the MR causal estimate towards zero 
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whereas in the 1-sample setting the causal effect estimate is biased towards the estimate from a 
standard cross-section analysis. Sample overlap in the 2-sample MR setting provides an 
intermediate level of protection against weak instrument bias proportional to the degree of 
overlap.24
Another attractive feature of 2-sample MR is that the analysis can be carried out using summary 
statistics (summary level data) from a GWAS for the exposure of interest and summary statistics 
from a GWAS for the outcome of interest. These summary statistics datasets, which include 
regression coefficients and associated standard errors, are often made publicly available by large 
research consortia who have accrued very large sample sizes. Platforms such as MR-Base25 facilitate 
access to these datasets and their integration with state-of-the-art analysis tools.
Sample size and statistical power
Most genetic variants associated with exposure variables have very small effect sizes. This imposes 
a requirement for extremely large sample sizes in order to gauge the impact of the variants – and 
thus the exposure – with a trait or disease outcome. Insufficient power will either lead to biased 
inference of the causal effect, or failure to identify a modestly-sized causal effect (as discussed 
above). With the advent of large-scale GWAS analyses from samples of hundreds of thousands of 
participants, lack of statistical power is becoming less of a limitation than in the past. It could be 
argued that performing studies using very, very large sample sizes will lead to the discovery of 
statistically significant but biologically meaningless findings. Nevertheless, a counter-argument is 
that so long as the effect sizes of risk factors are reported, not just their associated P-values, then the 
greater precision offered by a very large sample size will be generally be an advantage. Formulae 
for performing statistical power calculations for MR have been published.26-28
SENSITIVITY ANALYSES AND NEW DIRECTIONS
Tests for markers exhibiting horizontal pleiotropy
A number of tests have been proposed for detecting genetic variants with horizontally pleiotropic 
effects,29-32 which work under the assumption that variants with unusual variant-exposure and 
variant-outcome relationships are likely to be pleiotropic. A sensitivity analysis can be performed 
with these ‘outlier’ variants excluded. An interesting alternative is Steiger filtering,33 which 
identifies (and removes) variants that explain more of the variance in the outcome than the 
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exposure, under the assumption such variants may have reverse-causal relationships with the 
outcome and exposure (namely, genetic variant  outcome  exposure). 
Care is needed when interpreting the findings from all of the available outlier detection methods, 
and the related methods described below; for instance, an apparent outlier variant could be the 
only reliable instrumental variable if in fact all of the remaining variants have pleiotropic effects. 
Alternatively, even if a full set of genetic variants are valid instrumental variables, a variant with an 
unusually strong effect could still act as an outlier. See Hemani et al.34 for an in-depth discussion of 
these issues.
MR-Egger
The terms ‘directional pleiotropy’ and ‘balanced pleiotropy’ refer, respectively, to multiple variant 
MR analyses in which the weaker variants do or do not have effects biased in one direction. 
Directional pleiotropy can be visualized in a funnel plot of the causal effect estimate vs. 
instrumental variable ‘strength’ relationships35 or a scatter plot of the variant-outcome vs. variant-
exposure regression coefficients36 (Figure 3). In general, it is difficult to distinguish between bias 
arising from directional pleiotropy and bias arising from variants with pleiotropic effects on the 
outcome variable acting through a confounder, i.e. failure of the so-called InSIDE (Instrument 
Strength Independent of Direct Effect) assumption.
MR-Egger applies the principle of Egger-regression meta-analysis to multiple-variant MR.35 
Specifically, an intercept term is included in the model used to combine and weight the causal effect 
estimates from the genetic variants. Directional pleiotropy will shift the intercept away from zero 
while still providing a valid causal effect estimate.35 This is an informative and commonly-used 
sensitivity analysis, however the statistical power to detect a causal effect is reduced with MR-
Egger compared to a standard, inverse variance weighted (IVW) meta-analysis model for 
combining information from multiple MR variants.37
Median and Mode-based Mendelian Randomization estimates
Following the widespread adoption of MR-Egger, several alternative methods have been proposed 
for combining information in a multiple variant MR framework in order to reduce the influence of 
pleiotropy. Bowden et al.38 introduced the weighted median causal effect estimate, which is valid 
even if up to 50% of the information in the analysis is from genetic variants with horizontally 
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pleiotropic effects. Loosely, this can be interpreted as suggesting that a weighted median-based MR 
causal estimate will be reliable so long as at least half of the variants are valid instrumental 
variables. Along similar lines, Hartwig et al.39 proposed a mode-based estimator (MBE), which can 
potentially provide a reliable causal effect estimate even if the majority of instrumental variables 
are invalid because of pleiotropy. Both approaches are useful sensitivity analyses: caution is needed 
when interpreting findings if the IVW, weighted-median, and MBE estimates differ widely.
Multivariable Mendelian Randomization
Distinct from the use of multiple genetic variants to gauge the effect of a single exposure, 
multivariable MR employs multiple genetic variants to gauge the effects of an exposure while 
accounting for pleiotropic effects on one or more additional, specified exposures. To date, 
multivariable MR has been adopted most often in studies examining the risks conferred by different 
lipid traits.30,40-42 High-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglyceride 
levels in the blood are influenced by many genetic variants, some of which have pleiotropic effects 
on more than one lipid fraction. This makes single-exposure (univariable) MR studies of lipid traits 
difficult to interpret. However, by accounting for the effects of genetic variants on all three lipid 
traits simultaneously, multivariable MR has been used to disentangle the causal effect of 
triglycerides, HDL and LDL on AMD.40,43 MR-Egger can also be applied in the multivariable setting.44
New directions
The increasing popularity of MR has been accompanied by several innovative developments in 
recent months (reviewed by Zheng et al.45). MR is being applied on a genome-wide scale to leverage 
causal information from transcriptomics and epigenomics datasets.29,46-49 These approaches can 
help determine the genes and pathways through which GWAS variants exert their effects, which is 
an important goal in genetics.  
Methodological advances such as genetic instrumental variable (GIV) regression50 and mixture-of-
experts (MR-MoE) machine learning33 offer improved frameworks for drawing causal inferences. 
GIV regression utilizes summary statistics from two independent GWAS analyses for the outcome 
variable (or a split-sample GWAS for the outcome) so that genetic risk scores obtained from one 
dataset can be used as an instrumental variable for an MR analysis in the other dataset,50 and vice 
versa. This idea builds on an existing approach used to correct for measurement error.5 As a result, 
GIV regression has the potential to provide causal estimates free from bias due to horizontal 
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pleiotropy. MR-MoE provides a standardized approach for choosing from the myriad of available 
MR analysis methods (IVW, MR-Egger, weighted-median, MBE, etc.) the one that is most 
appropriate for a given situation.33 The approach works by categorizing features of the summary 
statistics of 2-sample MR analyses best suited to, say, an IVW MR analysis, and then applying the 
IVW method to subsequent datasets that match these features. To ‘train’ the MoE model, the 
authors simulated 2-sample MR datasets and used a random forest classifier to select the analysis 
method that provided the optimum trade-off between statistical power and bias from pleiotropic 
instrumental variables. 
Finally, Staley and Burgess51 have described two MR methods for assessing the ‘shape’ of the 
exposure-outcome causal relationship. Both approaches require access to individual level data. In 
an applied example, the methods were used to provide evidence of non-linearity in the causal 
relationship between body mass index (BMI) and blood pressure. A progressively higher BMI was 
found to cause progressively higher blood pressure across most of the BMI distribution, yet the 
relationship plateaued or reversed in hyper-obese individuals.51   
FURTHER GUIDANCE ON THE INTERPRETATION OF MENDELIAN RANDOMIZATION STUDIES
We highly recommend a recent BMJ article by Davies et al.52 for clinicians interested in learning 
more about how to interpret the strengths and weaknesses of published MR studies. This article 
provides guidance on how the plausibility of the MR assumptions in a published study can be 
gauged, since this is a key determinant of the weight of evidence of an MR study compared to other 
epidemiological approaches. In keeping with moves to standardise the reporting and interpretation 
of RCTs (e.g. CONSORT53, CASP), the authors provide a ‘critical appraisal checklist for evaluating MR 
studies’.
REVIEW OF MENDELIAN RANDOMIZATION STUDIES IN THE VISION SCIENCES
We conducted a literature search of PubMed and Web of Science to identify studies applying 
Mendelian randomization to study risk factors for eye disorders. The search was restricted to 
articles written in English and published in peer-reviewed journals between 2008 and 2018. The 
search strategy is described in the Appendix. Only 8 studies were identified (Table 1). 
Three of the ophthalmic MR studies we found addressed research questions relating to 
myopia.21,54,55 In the most recent of these, a UK research team tested the hypothesis that education 
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has a causal effect on myopia development. The results supported the hypothesis, confirming a 
similar conclusion from a smaller scale study carried out 2 years earlier.21 The other MR study 
examining risk factors for myopia55 provided evidence refuting a causal role for (low) serum 
vitamin D level in myopia development. This result implied that the association between serum 
vitamin D and refractive error observed in several cross-sectional epidemiology studies56-63 is non-
causal, most likely mediated by the time individuals spend outdoors. 
There were also 3 ophthalmic MR studies addressing research questions related to AMD.18,40,43 Two 
of the publications estimated the effect of plasma lipid levels on AMD, with both finding evidence of 
an effect of HDL cholesterol, but not for LDL cholesterol or triglycerides.40,43 As mentioned above, 
the other AMD-related study used MR to assess whether a low serum complement factor H (CFH) 
level predisposes individuals to AMD. The result was inconclusive, perhaps due to the use of only a 
single genetic variant as an instrumental variable.18 Notably, the latter study was published in 2013, 
whereas the remaining studies were all published in during the period 2016-2018.
A single study investigated primary open-angle glaucoma (POAG) as an outcome.64 Shen et al. found 
strong evidence from their MR analyses to support observational evidence that individuals with 
type-2 diabetes (T2D) are at an increased risk of glaucoma. Notably, Shen et al. carried out a series 
of separate MR analyses using allele scores designed to investigate the causal effects of specific 
mechanisms implicated in T2D pathogenesis (adiposity, -cell function, insulin regulation, and 
other metabolic processes) as well as a non-mechanism-specific, T2D allele score analysis. One 
reason why pathway-specific MR analyses such as this are not common in the literature is that they 
can be difficult to interpret, e.g. if genetic variants have pleiotropic effects on more than one disease 
mechanism; a problem analogous to the difficulty of inferring the causal effects of individual lipid 
traits using univariable rather than multivariable MR.  
The final ophthalmic MR study that we identified evaluated the risk associated with plasma HDL 
cholesterol, LDL cholesterol and triglycerides, on the incidence of diabetic retinopathy (DR).65 None 
of the 3 lipid fractions was found to be causally associated with the risk of DR, either when the 
outcome was ‘any DR’ or ‘severe DR’. However, the authors were careful to point out that the study 
had limited statistical power to detect subtle causal risks, since the GWAS sample size used to 
obtain genetic effect estimates for association with DR was relatively small (2,969 cases and 4,096 
controls).
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In summary, despite the increasing adoption of MR in fields of health research such as cardiology 
and rheumatology, the number of MR studies applying this approach to identify and to estimate the 
causal effect of risk factors for eye diseases remains limited. To date, the main ophthalmic-related 
outcomes of interest for researchers are myopia and AMD (Table 1).
CONCLUSIONS
GWAS summary statistics for a wide range of potential risk factors, analysed in samples of tens or 
hundreds of thousands of participants, are publically available. These summary statistics provide 
an excellent resource for identifying instrumental variables for use in MR. GWAS summary statistics 
are also available for several ophthalmic traits, including refractive error, diabetic retinopathy, 
intra-ocular pressure, glaucoma and cataract. Together, these resources can be harnessed to carry 
out 2-sample MR analyses for addressing a wide range of epidemiological research questions, 
facilitated by platforms such as MR-Base. Although the ophthalmic research community has been 
relatively slow to adopt MR compared to some disciplines, the approach offers significant potential 
for independently supporting and clarifying causal relationships inferred from observational 
studies, and for prioritizing investment in RCTs.
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Table 1. Mendelian randomization studies examining the effects of specific exposures on ophthalmic 
traits.
Study Exposure/ risk factor Outcome
Instrumental 
variable(s)
Findings
Sharma et al. (2013) 18
Complement factor H 
level
AMD 1 SNP Causal relationship
Burgess et al. (2017) 40 Plasma lipid levels AMD 185 SNPs
Causal effect of HDL 
Cholesterol 
Fan et al. (2017) 43 Plasma lipid levels AMD 185 SNPs
Causal effect of HDL 
Cholesterol
Cuellar-Partida et al. (2016) 21
Educational 
attainment
Myopia Allele score Causal relationship
Cuellar-Partida et al. (2017) 55
Serum vitamin D 
level
Myopia 6 SNPs No causal relationship
Mountjoy et al. (2018) 54
Educational 
attainment
Myopia Allele score Causal relationship
Shen et al. (2016) 64 Type 2 diabetes Glaucoma Allele score Causal relationship
Sobrin et al. (2017) 65 Plasma lipid levels
Diabetic 
retinopathy
157 SNPs No causal relationship
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Figure 1. Properties of an instrumental variable. Arrows depict causal relationships amongst 
variables, with solid arrows denoting known or strongly-suspected relationships and dashed 
arrows indicating putative relationships. Beta coefficients represent the strength of the causal 
relationships. The parameter of primary research interest is coefficient 2, which gauges the causal 
effect of the exposure on the outcome.
Figure 2. Analogy between a randomized controlled trial (RCT) and a Mendelian 
randomization (MR) analysis. Panel A: In an RCT, randomization serves, firstly, to cause an 
increase in the level of the exposure in the intervention group relative to the control group. 
Secondly, randomization serves to balance the levels of both known and unknown confounders 
between the intervention and control groups. Panel B: In an MR analysis, random assortment of 
alleles at meiosis creates the setting for a ‘natural experiment’ in which some individuals are 
genetically-predisposed to a higher level of the exposure than others. If the assortment of alleles 
during meiosis is not influenced by known or unknown confounders of the exposure-outcome 
relationship, then levels of these confounders will be balanced between the 2 groups (i.e. those with 
and without a genetic predisposition due to the genetic variant of interest).
Figure 3. MR sensitivity analyses. Panel A: Scatter plot of single nucleotide polymorphism (SNP) 
genetic variant regression coefficients quantifying the level of association with the exposure 
(Alzheimer’s disease; x-axis) and with the outcome (self-reported glaucoma; y-axis) in an MR 
analysis. The solid blue line represents the Inverse Variance Weighted (IVW) and the dashed green 
line the MR-Egger methods of combining information across variants. A possible outlier variant is 
shown in red. Error bars indicate 1 standard error (SE). Panel B: Funnel plot for the same MR 
analysis shown in A. Each data point represents a genetic variant. The possible outlier variant 
plotted in red in panel A is also plotted in red in panel B. Data for these plots were obtained from 
MR-Base,25 for the traits "UKB-a:79" (self-reported glaucoma in UK Biobank) and “#298” 
(Alzheimer’s disease66). The MR-Egger analysis suggests minimal evidence of directional pleiotropy, 
and both the IVW and MR-Egger analyses suggest negligible causal impact of Alzheimer’s disease on 
self-reported glaucoma.
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Appendix: Literature search methodology
PubMed (https://www.ncbi.nlm.nih.gov/pubmed)
Publication date: from 01/01/2008 to 15/07/2018
Search query:
("Mendelian Randomization Analysis"[Mesh] OR "Mendelian randomisation"[all fields] OR 
"Mendelian randomization"[all fields] OR (Mendelian[all fields] AND (("Mendelian Randomization 
Analysis"[Mesh] OR "Mendelian randomisation"[all fields] OR "Mendelian randomization"[all fields] 
OR (Mendelian[all fields] AND randomi*[all fields]) OR "genetic instrumental variable"[all fields] 
OR "genetic instrumental variables"[all fields] OR "genetic instrument"[all fields] OR "genetic 
instruments"[all fields] OR "genes as instruments"[all fields] OR "gene as instrument"[all fields] OR 
"genes as instrument"[all fields] OR "gene as instruments"[all fields] OR (instrument*[ti] AND 
(gene[ti] OR genes[ti] OR genetic*[ti] OR mendel*[ti])) OR (("instrumental variable"[all fields] OR 
"instrumental variables"[all fields] OR "instrumented analysis"[all fields] OR "instrumented 
analyses"[all fields] OR "instrumental variable analysis"[all fields] OR "instrumental variable 
analyses"[all fields] OR "instrumental variables analysis"[all fields] OR "instrumental variables 
analyses"[all fields]) AND (gene OR genes OR genetics OR mendel OR mendelian)) OR 
("mendelian"[all fields] AND ("randomisation"[all fields] OR "randomization"[all fields] OR 
"randomising"[all fields] OR "randomizing"[all fields])))) AND ("myopi*" OR "eye" OR "ophthalm*" 
OR "AMD" OR"macula*" OR"retin* " OR"glauc*" OR"refract*")
Web of Science (http://apps.webofknowledge.com)
Publication date: from 2008 to 2018
Language: English
Document types: Article
Search query:
TI=((("Mendelian randomisation" OR "Mendelian randomization" OR "genetic instrumental 
variable" OR "genetic instrumental variables" OR "genetic instrument" OR "genetic instruments" OR 
"mendel randomise" OR "mendel randomize" OR "mendel randomization" OR "mendel 
randomisation" OR "random Mendelian" OR "genes as instruments" OR "gene as instrument" OR 
"genes as instrument" OR "gene as instruments" OR "instrumental genetic variable" OR 
"instrumental genetic variable")) AND("myopi*" OR "eye" OR "ophthalm*" OR "AMD" OR"macula*" 
OR"retin*" OR"glauc*" OR"refract*")))
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Glossary: Terminology in Mendelian randomization studies
Assortative mating
Definition. Assortative mating refers to an individual’s choice of mate (spouse) being non-random. 
Positive and negative assortative mating refers to mate selection on the basis of similarity or 
dissimilarity for particular trait(s) of interest. Single trait assortative mating describes mate choice on 
the basis of just one trait, while cross-trait assortative mating occurs when individuals with a certain 
level of one trait choose mates with a certain level of another trait. Assortative mating has the 
potential to bias the causal estimate from a MR analysis even if the exposure and outcome are not 
directly subject to assortative mating.16 Hartwig et al.16 outline a method for correcting bias due to 
assortative mating using data from family members. 
Example. It has been suggested that assortative mating occurs for eye colour (an example of single 
trait assortative mating)67 and that cross-trait assortative mating is common across a range of 
psychiatric conditions.68
Collider bias (also known as collider stratification bias)
 
Definition. A collider is a variable that is affected by two or more downstream variables. Stratifying an 
analysis on the basis of a collider (or adjusting for a collider in a regression analysis) can introduce an 
entirely spurious association (or create a systematically over-estimated or under-estimated degree of 
association) between the downstream causal variables. 
 
Example. UV exposure and hyperopia are both risk factors for AMD.69 Hence, an analysis of patients 
with AMD (i.e. stratifying on AMS status) would risk identifying a purely spurious association 
between UV exposure and hyperopia. 
 
[ Figure 4 about here ]
Directional pleiotropy (also known as unbalanced pleiotropy)
Definition. The occurrence of horizontal pleiotropy in which the effects of genetic variants acting via 
confounding trait(s) are not balanced with respect to size and direction, i.e. either outcome-increasing 
or outcome-decreasing horizontally pleiotropic effects predominate. The MR-EGGER intercept test can 
be used to test for directional pleiotropy: under the null hypothesis of balanced pleiotropy, the 
intercept from an MR-EGGER analysis will be zero. The slope from an MR-EGGER analysis provides a 
valid causal effect estimate in the presence of directional pleiotropy, whereas a standard (inverse 
variance-weighted) causal effect estimate will be biased. 
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Example. The scatterplots show simulated data for a Mendelian randomization analysis, with SNP-
exposure and SNP-outcome effect sizes plotted on the x-axis and y-axis, respectively. In the plot on 
the left, the data were fitted using an inverse variance-weighted Mendelian randomization model, 
i.e. with the intercept constrained to zero (red dashed line). The steep slope of this line suggests a 
large causal effect estimate. In the plot on the right, the data were fitted using MR-EGGER. The black 
dotted line indicates the MR-EGGER intercept (the weighted mean SNP-outcome effect size). The 
shallow slope of the MR-EGGER regression line suggests a small causal effect estimate. A 
parsimonious interpretation is that the non-zero MR-EGGER intercept results from directional 
pleiotropy, and that the small causal effect estimate from the MR-EGGER analysis is better 
supported than the large causal effect estimate from the inverse variance-weighted analysis.
[ Figure 5 about here ]
Funnel plot
 
Definition. A funnel plot is a scatterplot of effect size (x-axis) versus precision (y-axis). If the 
distribution of points is asymmetric with respect to the average effect size, this may indicate a source 
of bias. Funnel plots are commonly used to test for publication bias (in which an asymmetric 
distribution may indicate bias towards publishing positive findings while not publishing negative 
findings). In Mendelian randomization, the data points of a funnel plot correspond to the causal effect 
estimate (x-axis) versus a measure of the genetic variant’s expected precision, e.g. the reciprocal of a 
genetic variant’s standard error for association with the outcome.70 Asymmetry in a Mendelian 
randomization funnel plot may indicate a departure from instrumental variable criteria #2 or #3, 
most likely due to horizontal pleiotropy, and thus suggest that the causal effect estimate is biased..
Example. Mendelian randomization funnel plots with symmetric (left) and asymmetric (right) 
profiles. 
[ Figure 6 about here ]
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Genetic variant (also known as a DNA sequence polymorphism)
 
Definition. A genetic variant is a difference in DNA sequence between individuals in a population at a 
specific position in the genome. The most common type is a single base difference, called a single 
nucleotide polymorphism (SNP). Other types of genetic variant include ‘indels’ (the insertion or 
deletion of one or more bases), microsatellite repeat polymorphisms (differences in the number of a 
repeating series of bases) and large structural rearrangements. The vast majority of genetic variants 
used in Mendelian randomization studies are SNPs, since they are common in the population, and 
inexpensive and accurate to determine (a process known as, ‘genotyping’). 
Example. Schematic diagram of a region of a chromosome 
containing a genetic variant. Individuals each carry two 
copies of the chromosome. Individual #1 is homozygous 
for the C nucleotide while individual #2 is heterozygous. 
Hydrogen bonds between bases of the two strands of the 
DNA double helix are indicated (= and ).
GWAS (Genome-wide association study)
Definition. A GWAS is a systematic search through the genome for genetic variants associated with a 
trait of interest. Each genetic variant is tested in turn, typically using logistic regression for 
case/control traits and using linear regression for quantitative traits. Because several million genetic 
variants are tested in a GWAS, the threshold chosen for declaring ‘genome-wide statistical 
significance’ is very stringent, e.g. P < 5 x 10-8. The full GWAS results (so called ‘summary statistics’) for 
a wide variety of potential exposure and outcome traits have been made freely available for download. 
Genetic variants identified in GWAS analyses are a source of potential instrumental variables for MR 
studies. Furthermore, in ‘2-sample MR’ study designs (in which separate samples of participants are 
used to quantify the genetic variant-exposure and the genetic variant-outcome relationships) all of the 
information required for the MR analysis can be obtained from GWAS summary statistics. The MR 
Base website25, has collected together information from available GWAS summary statistics to 
facilitate 2-sample MR analyses.
Horizontal pleiotropy and vertical pleiotropy
 
Definition. A genetic variant that has effects on more than one trait is said to exhibit pleiotropy. Of the 
various types of pleiotropy, horizontal and vertical pleiotropy are the forms most relevant to 
Mendelian randomization. In this context, a horizontally pleiotropic genetic variant has independent 
effects on both the exposure and at least one other trait that directly or indirectly influences the 
outcome. This invalidates a key instrumental variable requirement, namely, that the genetic variant 
[ Figure 7 about here ]
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influences the outcome only via the exposure (criterion #3). In the context of Mendelian 
randomization, a vertically pleiotropic genetic variant has non-independent effects on both the 
exposure and at least one other trait that directly or indirectly influences the outcome. Instrumental 
variable criterion #3 still holds for such a genetic variant. 
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Example. In a Mendelian randomization analysis designed to test for a causal role of carotenoid 
levels in protecting against AMD, a genetic variant that exerts an effect on carotenoid levels via 
education – an example of vertically pleiotropy – would be a valid instrumental variable (pathway 
diagram A). In contrast, a genetic variant with independent effects on carotenoid levels and 
education – an example of horizontal pleiotropy – would not be a valid instrumental variable since 
it will influence AMD risk via both a change in education and a change in carotenoid level, making it 
impossible to determine the role of carotenoids alone. 
[ Figure 8 about here ]
InSIDE (Instrument Strength Independent of Direct Effect) assumption
Definition. The InSIDE assumption posits that, for the set of genetic variants used in a Mendelian 
randomization analysis, the variants’ effects on the exposure are not correlated with their effects on 
other horizontally pleiotropic trait(s). The InSIDE assumption must be satisfied in order for the MR-
EGGER test to be a valid test for directional pleiotropy. Burgess et al.70 reason that the InSIDE 
assumption is more likely to be violated if the set of genetic variants’ pleiotropic effects act via a single 
confounder. With reference to Figure 1, the InSIDE assumption defines that the 1 coefficients for a set 
of variants are uncorrelated with their 5 and 6 coefficients.
Instrumental variable
Definition. An instrumental variable is a variable that meets the following three criteria: (1) it is 
robustly associated with the exposure of interest, (2) it is not associated with confounders of the 
exposure-outcome relationship, and (3) it is not associated with the outcome except via the exposure 
(see Figure 1). Since an instrumental variable is not associated with confounders (criterion #2) it can 
be used to gauge the impact of an exposure free from the confounder bias typically present in 
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observational studies. Furthermore, when genetic variants are used as instrumental variables, the risk 
of reverse causation is usually negligible, since it is much more likely that a genetic variant will 
influence an outcome via its effects on the exposure, than that an outcome will have altered an 
individual’s genotype. 
Example. Instrumental variables are widely used in econometrics. For example, Angrist71 used 
assignment into the United States armed forces by the Vietnam-era draft lottery as an instrumental 
variable to estimate the effects of military service on earnings in later civilian life. The draft lottery 
assigned individuals into military service at random and therefore would have been free from the 
influence of the usual confounders (socio-economic position, parental military service, etc.) that 
would otherwise bias estimates of the effect of military service on earnings.  
Weak instrument bias
Definition. Instrumental variables that are only weakly associated with the exposure (i.e. not 
satisfying instrumental variable criteria #1) will bias causal effect estimates.72 In a 1-sample 
Mendelian randomization analysis (i.e. the same sample of participants is used to determine both the 
genetic variant-exposure and genetic variant-outcome effects) weak instrument bias will be in the 
direction of the observational association between exposure and outcome. In a 2-sample Mendelian 
randomization analysis (i.e. different samples of participants are used to determine the genetic 
variant-exposure and genetic variant-outcome effects) weak instrument bias will be towards the null. 
Selecting genetic variants that attain genome-wide significance in a GWAS for the exposure as 
instrumental variables and performing the Mendelian randomization in a sufficiently large sample26-28 
will minimize the risk of weak instrument bias. A commonly used approach to examine the strength of 
an instrumental variable is to confirm that the F-statistic (Cragg-Donald F-statistic) from a variant-
exposure regression model is at least 10, although such an approach does not guarantee against weak 
instrument bias.73
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Figure 3 
17 m (300 x 300 DPI) 
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Figure 6 
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Figure 7 
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